{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:51:59Z","timestamp":1790124719548,"version":"4.0.1"},"reference-count":95,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.molmed.2022.02.010","type":"journal-article","created":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T22:21:26Z","timestamp":1648160486000},"page":"421-434","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Role of inflammasomes in HIV-1 infection and treatment"],"prefix":"10.1016","volume":"28","author":[{"given":"Xiangyu","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongbin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0456-3428","authenticated-orcid":false,"given":"Yi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmed.2022.02.010_bb0005","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1126\/science.6189183","article-title":"Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS)","volume":"220","author":"Barre-Sinoussi","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.molmed.2022.02.010_bb0010","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.immuni.2018.04.030","article-title":"Targeting the latent reservoir for HIV-1","volume":"48","author":"Sengupta","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.molmed.2022.02.010_bb0015","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1001\/jama.2020.17025","article-title":"Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2020 Recommendations of the International Antiviral Society-USA Panel","volume":"324","author":"Saag","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.molmed.2022.02.010_bb0020","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1074\/jbc.M116.749473","article-title":"Potent NLRP3 inflammasome activation by the HIV reverse transcriptase inhibitor abacavir","volume":"292","author":"Toksoy","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2022.02.010_bb0025","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/1346-8138.14074","article-title":"Immune reconstitution inflammatory syndrome in non-HIV immunosuppressed patients","volume":"45","author":"Sueki","year":"2018","journal-title":"J. Dermatol."},{"key":"10.1016\/j.molmed.2022.02.010_bb0030","doi-asserted-by":"crossref","DOI":"10.1172\/JCI138861","article-title":"NLRP3 inflammasome induces CD4+ T cell loss in chronically HIV-1-infected patients","volume":"131","author":"Zhang","year":"2021","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2022.02.010_bb0035","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nature12940","article-title":"Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection","volume":"505","author":"Doitsh","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2022.02.010_bb0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0075500","article-title":"IL-1Beta enriched monocytes mount massive IL-6 responses to common inflammatory triggers among chronically HIV-1 infected adults on stable anti-retroviral therapy at risk for cardiovascular disease","volume":"8","author":"Jalbert","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.molmed.2022.02.010_bb0045","doi-asserted-by":"crossref","first-page":"21716","DOI":"10.1074\/jbc.M114.566620","article-title":"HIV-1 infection induces interleukin-1beta production via TLR8 protein-dependent and NLRP3 inflammasome mechanisms in human monocytes","volume":"289","author":"Guo","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2022.02.010_bb0050","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1002\/eji.202149275","article-title":"Abortive HIV-1 RNA induces pro-IL-1beta maturation via protein kinase PKR and inflammasome activation in humans","volume":"51","author":"Stunnenberg","year":"2021","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.molmed.2022.02.010_bb0055","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s11481-016-9708-3","article-title":"HIV-1 viral protein R activates NLRP3 inflammasome in microglia: implications for HIV-1 associated neuroinflammation","volume":"12","author":"Mamik","year":"2017","journal-title":"J. NeuroImmune Pharmacol."},{"key":"10.1016\/j.molmed.2022.02.010_bb0060","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02939-20","article-title":"HIV-1 Vpr-induced proinflammatory response and apoptosis are mediated through the Sur1\u2013Trpm4 channel in astrocytes","volume":"11","author":"Li","year":"2020","journal-title":"mBio"},{"key":"10.1016\/j.molmed.2022.02.010_bb0065","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41423-019-0260-y","article-title":"NLRP3-dependent pyroptosis is required for HIV-1 gp120-induced neuropathology","volume":"17","author":"He","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.molmed.2022.02.010_bb0070","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1523\/JNEUROSCI.3045-16.2017","article-title":"HIV-1 Tat primes and activates microglial NLRP3 inflammasome-mediated neuroinflammation","volume":"37","author":"Chivero","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.molmed.2022.02.010_bb0075","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41586-018-0761-3","article-title":"PtdIns4P on dispersed trans-Golgi network mediates NLRP3 inflammasome activation","volume":"564","author":"Chen","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2022.02.010_bb0080","doi-asserted-by":"crossref","first-page":"6931","DOI":"10.1128\/JVI.77.12.6931-6945.2003","article-title":"Targeting of the human immunodeficiency virus type 1 envelope to the trans-Golgi network through binding to TIP47 is required for env incorporation into virions and infectivity","volume":"77","author":"Blot","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.molmed.2022.02.010_bb0085","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1073\/pnas.0408717102","article-title":"The trans-Golgi network-associated human ubiquitin-protein ligase POSH is essential for HIV type 1 production","volume":"102","author":"Alroy","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2022.02.010_bb0090","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0140-6736(18)31311-4","article-title":"HIV","volume":"392","author":"Ghosn","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.molmed.2022.02.010_bb0095","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.cell.2010.11.001","article-title":"Abortive HIV infection mediates CD4 T cell depletion and inflammation in human lymphoid tissue","volume":"143","author":"Doitsh","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2022.02.010_bb0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0051698","article-title":"Inflammation in HIV-infected patients: impact of HIV, lifestyle, body composition, and demography \u2013 a cross sectional cohort study","volume":"7","author":"Langkilde","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.molmed.2022.02.010_bb0105","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00666-19","article-title":"HIV-2 depletes CD4 T cells through pyroptosis despite Vpx-dependent degradation of SAMHD1","volume":"93","author":"Luo","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.molmed.2022.02.010_bb0110","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1016\/j.celrep.2019.02.095","article-title":"HIV-1 envelope overcomes NLRP3-mediated inhibition of F-actin polymerization for viral entry","volume":"28","author":"Paoletti","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.molmed.2022.02.010_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2019.108266","article-title":"Antagonistic role of IL-1ss and NLRP3\/IL-18 genetics in chronic HIV-1 infection","volume":"209","author":"Reis","year":"2019","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.molmed.2022.02.010_bb0120","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.bbrc.2016.03.153","article-title":"IL-1beta and IL-18 inhibition of HIV-1 replication in Jurkat cells and PBMCs","volume":"473","author":"Wang","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.molmed.2022.02.010_bb0125","doi-asserted-by":"crossref","DOI":"10.1126\/science.aad1210","article-title":"T helper 1 immunity requires complement\u2013driven NLRP3 inflammasome activity in CD4(+) T cells","volume":"352","author":"Arbore","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.molmed.2022.02.010_bb0130","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3389\/fimmu.2018.00214","article-title":"The NLRP3 inflammasome is upregulated in HIV-infected antiretroviral therapy-treated individuals with defective immune recovery","volume":"9","author":"Bandera","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molmed.2022.02.010_bb0135","doi-asserted-by":"crossref","first-page":"580","DOI":"10.3389\/fimmu.2017.00580","article-title":"Pathophysiology of CD4+ T-cell depletion in HIV-1 and HIV-2 infections","volume":"8","author":"Vidya Vijayan","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molmed.2022.02.010_bb0140","doi-asserted-by":"crossref","first-page":"3834","DOI":"10.1038\/s41598-017-04130-9","article-title":"Pyroptosis, superinfection, and the maintenance of the latent reservoir in HIV-1 infection","volume":"7","author":"Wodarz","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.molmed.2022.02.010_bb0145","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1089\/aid.2016.0234","article-title":"Caspase-1 activity in CD4 T cells is downregulated following antiretroviral therapy for HIV-1 infection","volume":"33","author":"Cai","year":"2017","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"10.1016\/j.molmed.2022.02.010_bb0150","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00280-019-03996-y","article-title":"Ganciclovir reduces irinotecan-induced intestinal toxicity by inhibiting NLRP3 activation","volume":"85","author":"Huang","year":"2020","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.molmed.2022.02.010_bb0155","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/QAI.0b013e31828f93bb","article-title":"Susceptibility to Mycobacterium tuberculosis infection in HIV-positive patients is associated with CARD8 genetic variant","volume":"63","author":"Pontillo","year":"2013","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.molmed.2022.02.010_bb0160","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/QAI.0b013e3182392ebe","article-title":"Polymorphisms in inflammasome' genes and susceptibility to HIV-1 infection","volume":"59","author":"Pontillo","year":"2012","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.molmed.2022.02.010_bb0165","doi-asserted-by":"crossref","DOI":"10.1126\/science.abe1707","article-title":"CARD8 is an inflammasome sensor for HIV-1 protease activity","volume":"371","author":"Wang","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.molmed.2022.02.010_bb0170","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2020105071","article-title":"CARD8 inflammasome activation triggers pyroptosis in human T cells","volume":"39","author":"Linder","year":"2020","journal-title":"EMBO J."},{"key":"10.1016\/j.molmed.2022.02.010_bb0175","doi-asserted-by":"crossref","DOI":"10.1038\/s41589-021-00964-7","article-title":"M24B aminopeptidase inhibitors selectively activate the CARD8 inflammasome","author":"Rao","year":"2022","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.molmed.2022.02.010_bb0180","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1128\/JVI.02297-15","article-title":"Next-generation mRNA sequencing reveals pyroptosis-induced CD4+ T cell death in early simian immunodeficiency virus-infected lymphoid tissues","volume":"90","author":"Lu","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.molmed.2022.02.010_bb0185","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/cei.12317","article-title":"Innate DNA sensing is impaired in HIV patients and IFI16 expression correlates with chronic immune activation","volume":"177","author":"Nissen","year":"2014","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.molmed.2022.02.010_bb0190","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/iji.12157","article-title":"Polymorphism in IFI16 affects CD4(+) T-cell counts in HIV-1 infection","volume":"41","author":"Booiman","year":"2014","journal-title":"Int. J. Immunogenet."},{"key":"10.1016\/j.molmed.2022.02.010_bb0195","doi-asserted-by":"crossref","first-page":"E4571","DOI":"10.1073\/pnas.1311669110","article-title":"IFI16 senses DNA forms of the lentiviral replication cycle and controls HIV-1 replication","volume":"110","author":"Jakobsen","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2022.02.010_bb0200","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1126\/science.1243640","article-title":"IFI16 DNA sensor is required for death of lymphoid CD4 T cells abortively infected with HIV","volume":"343","author":"Monroe","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.molmed.2022.02.010_bb0205","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.chom.2019.05.002","article-title":"IFI16 targets the transcription factor Sp1 to suppress HIV-1 transcription and latency reactivation","volume":"25","author":"Hotter","year":"2019","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.molmed.2022.02.010_bb0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008752","article-title":"Nuclear PYHIN proteins target the host transcription factor Sp1 thereby restricting HIV-1 in human macrophages and CD4+ T cells","volume":"16","author":"Bosso","year":"2020","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.molmed.2022.02.010_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2020.100236","article-title":"IFI16 knockdown in primary HIV-1 target cells","volume":"2","author":"Bosso","year":"2021","journal-title":"STAR Protoc."},{"key":"10.1016\/j.molmed.2022.02.010_bb0220","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3390\/v12050495","article-title":"Cellular factors targeting HIV-1 transcription and viral RNA transcripts","volume":"12","author":"Nchioua","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.molmed.2022.02.010_bb0225","first-page":"95","article-title":"Restriction factors expression decreases in HIV-1 patients after cART","volume":"44","author":"D'Urbano","year":"2021","journal-title":"New Microbiol."},{"key":"10.1016\/j.molmed.2022.02.010_bb0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0192845","article-title":"HIV replication is associated to inflammasomes activation, IL-1beta, IL-18 and caspase-1 expression in GALT and peripheral blood","volume":"13","author":"Feria","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.molmed.2022.02.010_bb0235","doi-asserted-by":"crossref","DOI":"10.1126\/science.abd0811","article-title":"Human NLRP1 is a sensor for double-stranded RNA","volume":"371","author":"Bauernfried","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.molmed.2022.02.010_bb0240","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.756471","article-title":"Landscape of T Cells transcriptional and metabolic modules during HIV infection based on weighted gene co-expression network analysis","volume":"12","author":"Xu","year":"2021","journal-title":"Front. Genet."},{"key":"10.1016\/j.molmed.2022.02.010_bb0245","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.3389\/fimmu.2019.01291","article-title":"Flagellin\/NLRC4 pathway rescues NLRP3-inflammasome defect in dendritic cells from HIV-infected patients: perspective for new adjuvant in immunocompromised individuals","volume":"10","author":"Dos Reis","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molmed.2022.02.010_bb0250","doi-asserted-by":"crossref","first-page":"E4671","DOI":"10.1073\/pnas.1602419113","article-title":"AIM2 inflammasome is activated by pharmacological disruption of nuclear envelope integrity","volume":"113","author":"Di Micco","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2022.02.010_bb0255","doi-asserted-by":"crossref","first-page":"27864","DOI":"10.1038\/srep27864","article-title":"Effect of cocaine on HIV infection and inflammasome gene expression profile in HIV infected macrophages","volume":"6","author":"Atluri","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.molmed.2022.02.010_bb0260","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1056\/NEJMra1615896","article-title":"HIV-associated cancers and related diseases","volume":"378","author":"Yarchoan","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2022.02.010_bb0265","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1016\/j.jacc.2017.05.012","article-title":"HIV-1-associated atherosclerosis: unraveling the missing link","volume":"69","author":"Kearns","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.molmed.2022.02.010_bb0270","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3389\/fcvm.2020.00095","article-title":"NLRP3 inflammasome signaling as a link between HIV-1 infection and atherosclerotic cardiovascular disease","volume":"7","author":"Mullis","year":"2020","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.molmed.2022.02.010_bb0275","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.014873","article-title":"Targeting inflammation to reduce atherosclerotic cardiovascular risk in people with HIV infection","volume":"9","author":"Titanji","year":"2020","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.molmed.2022.02.010_bb0280","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2022.02.010_bb0285","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1016\/j.jacc.2018.09.038","article-title":"IL-1beta inhibition reduces atherosclerotic inflammation in HIV infection","volume":"72","author":"Hsue","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.molmed.2022.02.010_bb0290","first-page":"4","article-title":"FDA panel says canakinumab not safe enough","volume":"1358","author":"Anon.","year":"2011","journal-title":"React. Wkly."},{"key":"10.1016\/j.molmed.2022.02.010_bb0295","series-title":"HIV Neurocognitive Disorders","author":"Mitra","year":"2021"},{"key":"10.1016\/j.molmed.2022.02.010_bb0300","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.yexmp.2019.03.008","article-title":"Role of the inflammasomes in HIV-associated neuroinflammation and neurocognitive disorders","volume":"108","author":"Katuri","year":"2019","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.molmed.2022.02.010_bb0305","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.phrs.2017.04.028","article-title":"Antidepressants induce autophagy dependent-NLRP3-inflammasome inhibition in major depressive disorder","volume":"121","author":"Alcocer-Gomez","year":"2017","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.molmed.2022.02.010_bb0310","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.amjms.2019.10.009","article-title":"HIV and the kidney: from HIV-associated nephropathy to reservoir","volume":"358","author":"Klotman","year":"2019","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.molmed.2022.02.010_bb0315","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00109-010-0719-x","article-title":"The molecular pathogenesis of HIV-1 associated nephropathy: recent advances","volume":"89","author":"Papeta","year":"2011","journal-title":"J. Mol. Med. (Berl.)"},{"key":"10.1016\/j.molmed.2022.02.010_bb0320","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ajpath.2015.10.002","article-title":"HIV promotes NLRP3 inflammasome complex activation in murine HIV-associated nephropathy","volume":"186","author":"Haque","year":"2016","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.molmed.2022.02.010_bb0325","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41581-019-0158-z","article-title":"The role of inflammasomes in kidney disease","volume":"15","author":"Komada","year":"2019","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.molmed.2022.02.010_bb0330","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1083\/jcb.200903124","article-title":"Glyburide inhibits the Cryopyrin\/Nalp3 inflammasome","volume":"187","author":"Lamkanfi","year":"2009","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.molmed.2022.02.010_bb0335","doi-asserted-by":"crossref","first-page":"4052","DOI":"10.4049\/jimmunol.1502203","article-title":"Aberrant inflammasome activation characterizes tuberculosis-associated immune reconstitution inflammatory syndrome","volume":"196","author":"Tan","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.molmed.2022.02.010_bb0340","doi-asserted-by":"crossref","first-page":"106","DOI":"10.2174\/1574892812666171027102627","article-title":"NLRP3 inflammasome activation inhibitors in inflammation-associated cancer immunotherapy: an update on the recent patents","volume":"13","author":"Kopalli","year":"2018","journal-title":"Recent Pat. Anticancer Drug Discov."},{"key":"10.1016\/j.molmed.2022.02.010_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2021.127837","article-title":"Synthesis of polyenylpyrrole derivatives with selective growth inhibitory activity against T\u2013cell acute lymphoblastic leukemia cells","volume":"37","author":"Yoshida","year":"2021","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.molmed.2022.02.010_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.116593","article-title":"Inflammasome as a promising therapeutic target for cancer","volume":"231","author":"Lee","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.molmed.2022.02.010_bb0355","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1042\/CS20210189","article-title":"Vincristine attenuates cardiac fibrosis through the inhibition of NLRP3 inflammasome activation","volume":"135","author":"Ge","year":"2021","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.molmed.2022.02.010_bb0360","doi-asserted-by":"crossref","first-page":"5759","DOI":"10.1016\/j.cell.2021.09.032","article-title":"Phase separation drives RNA virus-induced activation of the NLRP6 inflammasome","volume":"184","author":"Shen","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2022.02.010_bb0365","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/nature22967","article-title":"Nlrp9b inflammasome restricts rotavirus infection in intestinal epithelial cells","volume":"546","author":"Zhu","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2022.02.010_bb0370","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1038\/s41423-021-00740-6","article-title":"NLRP3 inflammasome activation and cell death","volume":"18","author":"Huang","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.molmed.2022.02.010_bb0375","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.molmed.2016.12.007","article-title":"Inflammasome priming in sterile inflammatory disease","volume":"23","author":"Patel","year":"2017","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.molmed.2022.02.010_bb0380","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.molcel.2017.08.017","article-title":"NLRP3 phosphorylation is an essential priming event for inflammasome activation","volume":"68","author":"Song","year":"2017","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molmed.2022.02.010_bb0385","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.3390\/ijms20133328","article-title":"The NLRP3 inflammasome: an overview of mechanisms of activation and regulation","volume":"20","author":"Kelley","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.molmed.2022.02.010_bb0390","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41421-020-0167-x","article-title":"Inflammasome activation and regulation: toward a better understanding of complex mechanisms","volume":"6","author":"Zheng","year":"2020","journal-title":"Cell Discov."},{"key":"10.1016\/j.molmed.2022.02.010_bb0395","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41586-019-1295-z","article-title":"Structural mechanism for NEK7-licensed activation of NLRP3 inflammasome","volume":"570","author":"Sharif","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2022.02.010_bb0400","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nm.3893","article-title":"Inflammasomes: mechanism of action, role in disease, and therapeutics","volume":"21","author":"Guo","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2022.02.010_bb0405","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41392-021-00507-5","article-title":"Pyroptosis: mechanisms and diseases","volume":"6","author":"Yu","year":"2021","journal-title":"Signal. Transduct. Target Ther."},{"key":"10.1016\/j.molmed.2022.02.010_bb0410","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201466","article-title":"Neutrophil-specific gain-of-function mutations in Nlrp3 promote development of cryopyrin-associated periodic syndrome","volume":"218","author":"Stackowicz","year":"2021","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molmed.2022.02.010_bb0415","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/imr.12884","article-title":"The NLRP1 and CARD8 inflammasomes","volume":"297","author":"Taabazuing","year":"2020","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.molmed.2022.02.010_bb0420","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/s41419-020-02865-4","article-title":"DPP8\/9 inhibitors activate the CARD8 inflammasome in resting lymphocytes","volume":"11","author":"Johnson","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.molmed.2022.02.010_bb0425","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1172\/JCI98642","article-title":"Loss-of-function CARD8 mutation causes NLRP3 inflammasome activation and Crohn's disease","volume":"128","author":"Mao","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2022.02.010_bb0430","doi-asserted-by":"crossref","first-page":"R52","DOI":"10.1186\/ar4483","article-title":"CARD8 is a negative regulator for NLRP3 inflammasome, but mutant NLRP3 in cryopyrin-associated periodic syndromes escapes the restriction","volume":"16","author":"Ito","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.molmed.2022.02.010_bb0435","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.4049\/jimmunol.1600760","article-title":"Periodic fever with aphthous stomatitis, pharyngitis, and cervical adenitis syndrome is associated with a CARD8 variant unable to bind the NLRP3 inflammasome","volume":"198","author":"Cheung","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.molmed.2022.02.010_bb0440","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/s41591-018-0082-y","article-title":"DPP8\/DPP9 inhibitor-induced pyroptosis for treatment of acute myeloid leukemia","volume":"24","author":"Johnson","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2022.02.010_bb0445","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.chom.2011.04.008","article-title":"IFI16 acts as a nuclear pathogen sensor to induce the inflammasome in response to Kaposi Sarcoma-associated herpesvirus infection","volume":"9","author":"Kerur","year":"2011","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.molmed.2022.02.010_bb0450","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.immuni.2012.02.014","article-title":"Structures of the HIN domain:DNA complexes reveal ligand binding and activation mechanisms of the AIM2 inflammasome and IFI16 receptor","volume":"36","author":"Jin","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.molmed.2022.02.010_bb0455","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/nature07725","article-title":"AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC","volume":"458","author":"Hornung","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2022.02.010_bb0460","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/ni.1932","article-title":"IFI16 is an innate immune sensor for intracellular DNA","volume":"11","author":"Unterholzner","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.molmed.2022.02.010_bb0465","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.cytogfr.2014.06.004","article-title":"IFI16: at the interphase between innate DNA sensing and genome regulation","volume":"25","author":"Jakobsen","year":"2014","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.molmed.2022.02.010_bb0470","doi-asserted-by":"crossref","first-page":"14391","DOI":"10.1038\/ncomms14391","article-title":"IFI16 is required for DNA sensing in human macrophages by promoting production and function of cGAMP","volume":"8","author":"Jonsson","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2022.02.010_bb0475","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.49500","article-title":"IFI16, a nuclear innate immune DNA sensor, mediates epigenetic silencing of herpesvirus genomes by its association with H3K9 methyltransferases SUV39H1 and GLP","volume":"8","author":"Roy","year":"2019","journal-title":"Elife"}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147149142200051X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147149142200051X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T07:25:36Z","timestamp":1761463536000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S147149142200051X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":95,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S147149142200051X"],"URL":"https:\/\/doi.org\/10.1016\/j.molmed.2022.02.010","relation":{},"ISSN":["1471-4914"],"issn-type":[{"value":"1471-4914","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of inflammasomes in HIV-1 infection and treatment","name":"articletitle","label":"Article Title"},{"value":"Trends in Molecular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmed.2022.02.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}